Low sensitivity to dual MEK/Bcl‐2 inhibition observed in some cell lines, particularly those of MCL origin, could be explained by high expression levels of the antiapoptotic Bcl‐2 family proteins Mcl‐1 or Bcl‐xL. The gene discussed is BCL2; the disease is mantle cell lymphoma.